⌘K
Loading ticker…
DiaMedica Therapeutics Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, DiaMedica Therapeutics Inc. Common Stock (DMAC) has a 3-month relative strength percentile of 33 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 51. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.7%, relative volume 5.48×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
33 is not yet a leadership-grade RS read, Market Stance is 47
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
DMAC is in a stage 1 base, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 8.1% / -8.6%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
DMAC is held by 3 ETFs as of Mar 2026. Top owner: IWM at 0.01% weight, $6M notional. Top 3 carry $10M.
Top 3 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IWMiShares Russell 2000 ETF | 0.01% | $6M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| IWOiShares Russell 2000 Growth ETF | 0.02% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DMAC Jan avg: -2.05% median: 0.15% win: 50% σ: 8.83% n: 4 2022-04-12 → 2026-05-29 | DMAC Feb avg: 11.70% median: 9.88% win: 75% σ: 12.46% n: 4 2022-04-12 → 2026-05-29 | DMAC Mar avg: -19.01% median: -13.20% win: 0% σ: 15.58% n: 4 2022-04-12 → 2026-05-29 | DMAC Apr avg: -0.03% median: 3.11% win: 60% σ: 9.09% n: 5 2022-04-12 → 2026-05-29 | DMAC May avg: 16.98% median: 4.74% win: 60% σ: 28.94% n: 5 2022-04-12 → 2026-05-29 | DMAC Jun avg: 9.50% median: -1.69% win: 50% σ: 33.39% n: 4 2022-04-12 → 2026-05-29 (current) | DMAC Jul avg: -5.17% median: -5.06% win: 50% σ: 17.27% n: 4 2022-04-12 → 2026-05-29 | DMAC Aug avg: 12.42% median: 13.54% win: 75% σ: 20.31% n: 4 2022-04-12 → 2026-05-29 | DMAC Sep avg: -3.89% median: -2.96% win: 50% σ: 21.98% n: 4 2022-04-12 → 2026-05-29 | DMAC Oct avg: -3.32% median: -1.04% win: 50% σ: 9.05% n: 4 2022-04-12 → 2026-05-29 | DMAC Nov avg: 16.10% median: 17.08% win: 100% σ: 12.45% n: 4 2022-04-12 → 2026-05-29 | DMAC Dec avg: 9.36% median: 6.21% win: 50% σ: 18.88% n: 4 2022-04-12 → 2026-05-29 |